Update from TASCI, a Nationwide, Randomized, Sham-controlled, Double-blind Clinical Trial on Transcutaneous Tibial Nerve Stimulation in Patients with Acute Spinal Cord Injury to Prevent Neurogenic Detrusor Overactivity

Martina D Liechti,Stéphanie Van Der Lely,Stephanie A Stalder,Collene E Anderson,Veronika Birkhäuser,Lucas M Bachmann,Martin W.G Brinkhof,Armin Curt,Xavier Jordan,Lorenz Leitner,Ulrich Mehnert,Sandra Möhr,Jürgen Pannek,Martin Schubert,Thomas M Kessler

doi:10.1016/j.euf.2019.09.019

Update from TASCI, a Nationwide, Randomized, Sham-controlled, Double-blind Clinical Trial on Transcutaneous Tibial Nerve Stimulation in Patients with Acute Spinal Cord Injury to Prevent Neurogenic Detrusor Overactivity

Martina D Liechti, Stéphanie Van Der Lely + Show 13 more

https://doi.org/10.1016/j.euf.2019.09.019

Copy DOI

Journal: European Urology Focus	Publication Date: Oct 8, 2019
Citations: 6

Affiliation: University of Zurich, University of Lucerne, Medignition (Switzerland), Clinique Romande de Réadaptation, Swiss Paraplegic Center, University Hospital of Bern

#Transcutaneous Tibial Nerve Stimulation #Tract Dysfunction In Patients + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Transcutaneous tibial nerve stimulation has the potential to revolutionize the management of lower urinary tract dysfunction in patients with acute spinal cord injury. TASCI is a nationwide randomized, sham-controlled, double-blind clinical trial for which the preparatory phase has been successfully completed.

Full Text